Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual total long term liabilities is $0.00, unchanged on December 31, 2022.
- During the last 3 years, DFFN annual total long term liabilities has fallen by -$2.25 million (-100.00%).
Performance
DFFN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly total long term liabilities is $0.00, unchanged on June 30, 2023.
- Over the past year, DFFN quarterly long term liabilities has stayed the same.
Performance
DFFN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
DFFN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
DFFN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Diffusion Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $443.90 K(-1.9%) |
| Mar 2021 | - | $452.70 K(-5.6%) |
| Dec 2020 | $479.60 K(-78.7%) | $479.60 K(-5.1%) |
| Sep 2020 | - | $505.60 K(-62.1%) |
| Jun 2020 | - | $1.33 M(-28.6%) |
| Mar 2020 | - | $1.87 M(-17.1%) |
| Dec 2019 | $2.25 M(+26.2%) | $2.25 M(+54.4%) |
| Sep 2019 | - | $1.46 M(-14.6%) |
| Jun 2019 | - | $1.71 M(-7.1%) |
| Mar 2019 | - | $1.84 M(+3.0%) |
| Dec 2018 | $1.79 M(-19.7%) | $1.79 M(+2.6%) |
| Sep 2018 | - | $1.74 M(-11.0%) |
| Jun 2018 | - | $1.96 M(-12.1%) |
| Mar 2018 | - | $2.22 M(-0.1%) |
| Dec 2017 | $2.23 M(-42.4%) | $2.23 M(-32.1%) |
| Sep 2017 | - | $3.28 M(0.0%) |
| Jun 2017 | - | $3.28 M(-15.1%) |
| Mar 2017 | - | $3.86 M(+0.0%) |
| Dec 2016 | $3.86 M(+355.9%) | $3.86 M(-0.5%) |
| Sep 2016 | - | $3.88 M(-6.2%) |
| Jun 2016 | - | $4.14 M(+0.3%) |
| Mar 2016 | - | $4.12 M(+387.0%) |
| Dec 2015 | $846.90 K(-62.8%) | $846.90 K(-62.8%) |
| Sep 2015 | - | $2.27 M(0.0%) |
| Jun 2015 | - | $2.27 M(0.0%) |
| Mar 2015 | - | $2.27 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $2.27 M(-24.2%) | $2.27 M(-52.3%) |
| Sep 2014 | - | $4.77 M(-6.5%) |
| Jun 2014 | - | $5.10 M(+44.2%) |
| Mar 2014 | - | $3.54 M(+17.9%) |
| Dec 2013 | $3.00 M(>+9900.0%) | $3.00 M(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $625.00 K(0.0%) |
| Jun 2011 | - | $625.00 K(0.0%) |
| Mar 2011 | - | $625.00 K(0.0%) |
| Dec 2010 | $625.00 K(0.0%) | $625.00 K(0.0%) |
| Sep 2010 | - | $625.00 K(0.0%) |
| Jun 2010 | - | $625.00 K(0.0%) |
| Mar 2010 | - | $625.00 K(0.0%) |
| Dec 2009 | $625.00 K(0.0%) | $625.00 K(0.0%) |
| Sep 2009 | - | $625.00 K(0.0%) |
| Jun 2009 | - | $625.00 K(-37.5%) |
| Mar 2009 | - | $1.00 M(+60.0%) |
| Dec 2008 | $625.00 K(-37.5%) | $625.00 K(-37.5%) |
| Sep 2008 | - | $1.00 M(0.0%) |
| Jun 2008 | - | $1.00 M(0.0%) |
| Mar 2008 | - | $1.00 M(0.0%) |
| Dec 2007 | $1.00 M(>+9900.0%) | $1.00 M(>+9900.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00 |
| Dec 2005 | $0.00(-100.0%) | - |
| Dec 1999 | $2.57 M(-68.7%) | - |
| Dec 1998 | $8.20 M | - |
FAQ
- What is Diffusion Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Diffusion Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Diffusion Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of DFFN is $0.00
What is the all time high annual total long term liabilities for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual total long term liabilities is $8.20 M
What is Diffusion Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, DFFN annual total long term liabilities has changed by $0.00 (0.00%)
What is Diffusion Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of DFFN is $0.00
What is the all time high quarterly long term liabilities for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly total long term liabilities is $5.10 M
What is Diffusion Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, DFFN quarterly total long term liabilities has changed by $0.00 (0.00%)